Activities per year
Activities
- 1 - 50 out of 65 results
Search results
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Jonathan Douxfils (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Invited speaker)
7 Nov 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Speaker)
14 Nov 2023Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Jonathan Douxfils (Speaker) & Laure Morimont (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Jonathan Douxfils (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
2nd NETSKINMODELS COST meeting
Yves Poumay (Invited speaker)
13 Sept 2023 → 15 Sept 2023Activity: Talk or presentation types › Invited talk
-
GRC meeting: Barrier Function of Mammalian Skin
Yves Poumay (Invited speaker)
6 Aug 2023 → 11 Aug 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Jonathan Douxfils (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Jonathan Douxfils (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
APC resistance as a marker of the risk of VTE in users of oral contraceptives. Practical usefulness for industry and for clinicians
Jonathan Douxfils (Invited speaker)
26 May 2023Activity: Talk or presentation types › Invited talk
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Jonathan Douxfils (Invited speaker) & Laure Morimont (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis - Interplay between platelets and coagulation
Jonathan Douxfils (Keynote speaker)
24 Nov 2022Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Jonathan Douxfils (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Jonathan Douxfils (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Acquired APC resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Jonathan Douxfils (Speaker) & Guillaume Chatel (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Jonathan Douxfils (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Jonathan Douxfils (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Jonathan Douxfils (Speaker)
4 Jul 2022Activity: Talk or presentation types › Invited talk
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Jonathan Douxfils (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Monitoring des anticoagulants: Artéfacts ou avantages - Anticoagulants directs oraux
Jonathan Douxfils (Speaker)
20 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Jonathan Douxfils (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
The cystine/glutamate xCT antiporter: yet another glial glutamate transporter modulating recovery following spinal cord injury?
Charles Nicaise (Speaker)
21 May 2022Activity: Talk or presentation types › Invited talk
-
Role of Cystine/glutamate antiporter in the spinal cord
Charles Nicaise (Speaker)
13 Mar 2022Activity: Talk or presentation types › Invited talk
-
In vitro and in vivo models of cardiac ischemia : Past and Future
Julie Laloy (Speaker)
21 Mar 2022Activity: Talk or presentation types › Invited talk
-
10 ans de monitoring des anticoagulants oraux. Où en sommes-nous et où allons-nous?
Jonathan Douxfils (Speaker)
15 Mar 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
In vitro toxicological assessment and hemocompatibility of squalene-based nanoparticles
Julie Laloy (Speaker)
8 Nov 2021Activity: Talk or presentation types › Invited talk
-
Impact of nanomaterials on haemodynamic parameters in normal and disease conditions.
Julie Laloy (Speaker)
27 Sept 2021Activity: Talk or presentation types › Invited talk
-
Measurement of Direct Oral Anticoagulants and Contact Pathway Inhibitors
Jonathan Douxfils (Invited speaker)
18 Jul 2021Activity: Talk or presentation types › Invited talk
-
Thrombotic risk associated with COVID- 19 pathogenesis and unusual thrombosis associated with thrombocytopenia in the context of COVID-19 vaccination
Jonathan Douxfils (Invited speaker)
24 Jun 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients After Two Doses of BNT162b2
Julien Favresse (Invited speaker) & Jonathan Douxfils (Invited speaker)
7 Jun 2021Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): Impact on hemostasis
Jonathan Douxfils (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing antibodies in COVID-19: Current knowledge and perspectives
Jonathan Douxfils (Invited speaker)
16 Mar 2021Activity: Talk or presentation types › Invited talk
-
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Jonathan Douxfils (Invited speaker) & Laure Morimont (Invited speaker)
4 Feb 2021Activity: Talk or presentation types › Invited talk
-
Utilisation des tests chromogéniques anti-FXa dans le cadre du suivi de l’HNF et des HBPM: principes de base et recommandations
Jonathan Douxfils (Invited speaker)
9 Feb 2021Activity: Talk or presentation types › Invited talk
-
Restoring faith in COC - An important hemostasis update
Jonathan Douxfils (Speaker)
2 Dec 2020Activity: Talk or presentation types › Invited talk
-
Monitoring of anticoagulant drugs
Jonathan Douxfils (Speaker)
16 Sept 2020Activity: Talk or presentation types › Invited talk
-
How to Measure Lupus Anticoagulants During DOAC Treatment?
Jonathan Douxfils (Speaker)
12 Jul 2020Activity: Talk or presentation types › Invited talk
-
Laboratory testing in patients treated with DOACs: a practical guide for clinicians and lab scientists
Jonathan Douxfils (Speaker)
22 Oct 2019Activity: Talk or presentation types › Invited talk
-
Pilule et thrombose : risques et contrôle biologique
Jonathan Douxfils (Speaker)
14 Oct 2019Activity: Talk or presentation types › Invited talk
-
Hemocompatibility of nanodrugs: Guidelines
Julie Laloy (Speaker)
23 May 2019Activity: Talk or presentation types › Invited talk
-
The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field
Jonathan Douxfils (Invited speaker)
19 Mar 2019Activity: Talk or presentation types › Invited talk
-
Le syndrome de chevauchement Asthme-BPCO; le point de vue du "BPCOlogue"
Éric Marchand (Speaker)
6 Oct 2018Activity: Talk or presentation types › Invited talk